Admasu FT, Dejenie TA, Ayehu GW, Zewde EA, Dessie G, Adugna DG, Enyew EF, Geto Z, Abebe EC (2023) Evaluation of thromboembolic event, basic coagulation parameters, and associated factors in patients with colorectal cancer: a multicenter study
Product works Rated 5 out of 5 Diane (verified owner) Rated 5 out of 5 Anonymous (verified owner) LOVE
- Near the freezer compartment or against the back wall if your fridge runs cold
GLP-1 Receptor Agonist / Antidiabetic Agent Semaglo 0.25 mg Injection is indicated for: Type 2 Diabetes Mellitus (T2DM): As an adjunct to diet and exercise to improve glycemic control in adults In combination therapy: Can be used alongside metformin, sulfonylureas, SGLT2 inhibitors, or insulin when additional glycemic control is needed Weight management support: Helps reduce body weight in overweight or obese diabetic patients as part of comprehensive management Semaglutide is a long-acting GLP-1 receptor agonist that mimics the effects of endogenous GLP-1